Atara Biotherapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Great. Good afternoon, everyone. Thanks for joining us. I'm Salveen Richter. I cover biotechnology at Goldman Sachs, and we're really pleased to have the Atara team here with us. We have Pascal Touchon, President and CEO; and Cokey Nguyen, CSO.
Questions & Answers
So with that, Pascal, maybe you could just provide a brief overview of the company and kind of where everything stands at this point between commercialization efforts and the pipeline efforts and where we should be thinking about launch aspects or understanding the launch aspects as well as the data sets that are coming over the next year or so.
Thank you, Salveen, for your question. I mean Atara is really the leading company in the field of allogeneic T-cell therapy. And we can say that because we are the first and so far
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
